<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Bone and soft tissue sarcomas, tumors of the skin</journal-id><journal-title-group><journal-title xml:lang="en">Bone and soft tissue sarcomas, tumors of the skin</journal-title><trans-title-group xml:lang="ru"><trans-title>Саркомы костей, мягких тканей и опухоли кожи</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2219-4614</issn><issn publication-format="electronic">2782-3687</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">79</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>BONE SARCOMAS</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>САРКОМЫ КОСТЕЙ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Spinal metastases: current trends at solving problems</article-title><trans-title-group xml:lang="ru"><trans-title>Метастатические поражения позвоночника. Современные аспекты диагностики и лечения</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Ivliev</surname><given-names>D. S.</given-names></name><name xml:lang="ru"><surname>Ивлиев</surname><given-names>Д. С.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>ivlievdenis95@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Lyulin</surname><given-names>S. V.</given-names></name><name xml:lang="ru"><surname>Люлин</surname><given-names>С. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Balaev</surname><given-names>P. I.</given-names></name><name xml:lang="ru"><surname>Балаев</surname><given-names>П. И.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff3"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Federal State Budget Institution «Federal Center of Traumatology, Orthopedics and Endoprosthetics» of the Ministry of Health of the Russian Federation</institution></aff><aff><institution xml:lang="ru">Федеральное государственное бюджетное учреждение «Федеральный центр травматологии, ортопедии и эндопротезирования» Министерства здравоохранения Российской Федерации (г. Смоленск)</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Federal State Budget Educational Institution of Higher Education «Ural State Medical University» of the Ministry of Health of the Russian Federation</institution></aff><aff><institution xml:lang="ru">Федеральное государственное бюджетное образовательное учреждение высшего образования «Уральский государственный медицинский университет» Министерства здравоохранения Российской Федерации</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">State Budget Institution «Kurgan Regional Oncological Center»</institution></aff><aff><institution xml:lang="ru">Государственное бюджетное учреждение «Курганский областной онкологический диспансер»</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2020-04-16" publication-format="electronic"><day>16</day><month>04</month><year>2020</year></pub-date><volume>12</volume><issue>1</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>32</fpage><lpage>43</lpage><history><date date-type="received" iso-8601-date="2021-04-16"><day>16</day><month>04</month><year>2021</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2020, Ivliev D.S., Lyulin S.V., Balaev P.I.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2020, Ивлиев Д.С., Люлин С.В., Балаев П.И.</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="en">Ivliev D.S., Lyulin S.V., Balaev P.I.</copyright-holder><copyright-holder xml:lang="ru">Ивлиев Д.С., Люлин С.В., Балаев П.И.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://sarbon.abvpress.ru/jour/article/view/79">https://sarbon.abvpress.ru/jour/article/view/79</self-uri><abstract xml:lang="en"><p>Metastasis of malignant tumors to the spine is a common problem in cancer patients and occurs through the hematogenous route. The main symptoms of spinal metastases are pain and neurological disorders. Modern imaging methods make it possible to verify tumor metastases. Indications for surgical treatments are determined with the help of prognostic scales, which also can help predict the treatment results. The optimal treatment is the combination of surgical treatment and radiation therapy. The sequence of surgical treatment and radiation therapy is still debatable. Systemic therapy is also an integral part of long-term control of spinal metastases and depends on the histological structure of the tumor and its ability to respond to drug exposure. Today there is no consensus and an unambiguous standardized, scientifically substantiated approach to solve the existing problem. However, further study of it will be able to provide the choice of the optimal algorithm for curation of patients with metastatic spinal lesions.</p></abstract><trans-abstract xml:lang="ru"><p>Метастазирование злокачественных опухолей в позвоночник является распространенной проблемой онкологических пациентов и происходит гематогенным путем. Проявляются метастазы позвоночника болью и неврологическими расстройствами. Современные методы визуализации позволяют верифицировать опухолевые поражения. С помощью прогностических шкал определяются показания к хирургическому лечению и прогнозируются его результаты. Оптимальным является сочетание хирургического лечения и лучевой терапии. Очередность проведения хирургического лечения и лучевой терапии по-прежнему остается дискутабельной. Системная терапия также является неотъемлемой частью долгосрочного контроля над спинальными метастазами и зависит от гистологической структуры опухоли и ее способности реагировать на медикаментозное воздействие. На сегодняшний день нет единства взглядов и однозначного стандартизированного, научно обоснованного подхода к решению существующей проблемы, однако дальнейшее ее изучение сможет обеспечить выбор оптимального алгоритма курации пациентов с метастатическим поражением позвоночника.</p></trans-abstract><kwd-group xml:lang="en"><kwd>prognostics scales</kwd><kwd>surgical treatment of spinal metastases</kwd><kwd>radiation therapy</kwd><kwd>management of metastatic spine disease</kwd><kwd>prognostics factors in patients with spinal metastases</kwd><kwd>scoring system for preoperative evaluation of metastatic spine tumor prognosis</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>профилактика метастатических поражений позвоночника</kwd><kwd>хирургическое лечение метастазов</kwd><kwd>прогностические шкалы</kwd><kwd>лучевая терапия метастазов</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics, 2000. CA Cancer J Clin. 2000;50(1):7-33. DOI: 10.3322/ canjclin.50.1.7.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Delank KS, Wendtner C, Eich HT, Eysel P. Therapy of spinal metastases. Dtsch Arztebl Int 2011;108(5):71-80. DOI: 10.3238/arztebl.2011.0071.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Sciubba DM, Petteys RJ, Dekutoski MB, Fisher CG, Fehlings MG, Ondra SL et al. Diagnosis and management of metastatic spine disease. A review. J Neurosurg Spine. 2010;13:94-108.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Joaquim Andrei F., Ann Powers, Ilya Laufer, Mark H. Bilsky Arq Neuropsiquiatr. 2015;73(9):795-802. An update in the anagement of spinal metastases. DOI: 10.1590/0004-282X20150099.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>White AP, Kwon BK, Lindskog DM, Friedlaender GE, Grauer JN. Metastatic disease of the spine. J Am Acad Orthop Surg. 2006;14:587-598.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Gupta GP, Massagué J. Cancer metastasis: building a framework. Cell. 2006;127:679-695.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Sciubba DM, Gokaslan ZL. Diagnosis and management of metastatic spine disease. Surg Oncol. 2006;15:141-151.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Perrin RG, Livingston KE, Aarabi B. Intradural extramedullary spinal metastasis. A report of 10 cases. J Neurosurg. 1982;56:835-837.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Bhatt AD, Schuler JC, Boakye M, Woo SY. Current and emerging concepts in non-invasive and minimally invasive management of spine metastasis. Cancer Treat Rev. 2013;39:142-152.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Laufer I, Sciubba DM, Madera M, Bydon A, Witham TJ, Gokaslan ZL et al. Surgical management of metastatic spinal tumors. Cancer Control. 2012;19:122-128.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>LaFrance L, Cassidy J, Nykoliation J, Mierau D. Back pain and spinal metastases: A case study. J Can Chiropr Assoc. 1987;31:69-72.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Siemionow K, Steinmetz M, Bell G, Ilaslan H, McLain RF. Identifying serious causes of back pain: cancer, infection, fracture. Cleve Clin J Med. 2008;75:557-566.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Ross MD, Bayer E. Cancer as a cause of low back pain in a patient seen in a direct access physical therapy setting. J Orthop Sports Phys Ther. 2005;35:651-658.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Gokaslan ZL. Spine surgery for cancer. Curr Opin Oncol. 1996;8:178-181.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Mercadante S. Malignant bone pain: pathophysiology and treatment. Pain. 1997;69:1-18.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Harel R, Angelov L. Spine metastases: current treatments and future directions. Eur J Cancer. 2010;46:2696-2707.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Van der Linden YM, Dijkstra SP, Vonk EJ, Marijnen CA, Leer JW Dutch Bone Metastasis Study Group. Prediction of survival in patients with metastases in the spinal column: results based on a randomized trial of radiotherapy. Cancer. 2005;103:320-328.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Jacobs WB, Perrin RG. Evaluation and treatment of spinal metastases: an overview. Neurosurg Focus. 2001;11:e10.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>SchiffD. Spinal cord compression. Neurol Clin. 2003;21:67-86.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Arguello F, Baggs RB, Duerst RE, Johnstone L, McQueen K, Frantz CN. Pathogenesis of vertebral metastasis and epidural spinal cord compression. Cancer. 1990;65:98-106.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Edelstyn GA, Gillespie PJ, Grebbell FS. The radiological demonstration of osseous metastases. Experimental observations. Clin Radiol. 1967;18:158-162.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Jung HS, Jee WH, McCauley TR, Ha KY, Choi KH. Discrimination of metastatic from acute osteoporotic compression spinal fractures with MR imaging. Radiographics. 2003;23:179-187.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Buhmann Kirchhoff S, Becker C, Duerr HR, Reiser M, Baur-Melnyk A. Detection of osseous metastases of the spine: comparison of high resolution multi-detector-CT with MRI. Eur J Radiol. 2009;69:567-573.</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Eleraky M, Papanastassiou I, Vrionis FD. Management of metastatic spine disease. Curr Opin Support Palliat Care. 2010;4:182-188.</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Bai J, Bakula A, Fellows DW, Ollenschleger MD, Kureshi IU, Spiegel GR. Novel application of 3-dimensional rotational C-arm conebeam CT angiography for metastatic hypervascular tumor mass in the spine. Spine (Phila Pa 1976). 2013;39:e300-303.</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Costelloe CM, Rohren EM, Madewell JE, Hamaoka T, Theriault RL, Yu TK et al. Imaging bone metastases in breast cancer: techniques and recommendations for diagnosis. Lancet Oncol. 2009;10:606-614.</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Scutellari PN, Antinolfi G, Galeotti R, Giganti M. Metastatic bone disease. Strategies for imaging]. Minerva Med. 2003;94:77-90.</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Savelli G, Maffioli L, Maccauro M, De Deckere E, Bombardieri E. Bone scintigraphy and the added value of SPECT (single photon emission tomography) in detecting skeletal lesions. Q J Nucl Med. 2001;45:27-37.</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Even-Sapir E, Martin RH, Barnes DC, Pringle CR, Iles SE, Mitchell MJ. Role of SPECT in differentiating malignant from benign lesions in the lower thoracic and lumbar vertebrae. Radiology. 1993;187:193-198.</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Gates GF. SPECT imaging of the lumbosacral spine and pelvis. Clin Nucl Med. 1988;13:907-914.</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Helyar V, Mohan HK, Barwick T Livieratos L, Gnanasegaran G, Clarke SE et al. The added value of multislice SPECT/CT in patients with equivocal bony metastasis from carcinoma of the prostate. Eur J Nucl Med Mol Imaging. 2010;37:706-713.</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Zhang Y Shi H, Gu Y, Xiu Y, Li B, Zhu W et al. Differential diagnostic value of single-photon emission computed tomography/spiral computed tomography with tc-99m-methylene diphosphonate in patients with spinal lesions. Nucl Med Commun. 2011;32:1194-1200.</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Costelloe CM, Rohren EM, Madewell JE, Hamaoka T, Theriault RL, Yu TK et al. Imaging bone metastases in breast cancer: techniques and recommendations for diagnosis. Lancet Oncol. 2009;10:606-614.</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Poulsen MH, Petersen H, H ilund-Carlsen PF, Jakobsen JS, Gerke O, Karstoft J et al. Spine Metastases in Prostate Cancer: Comparison of MDP Wholebody Bone Scintigraphy, Choline PET/CT, and NaF PET/CT. BJU Int. 2013:34-38.</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Schirrmeister H, Guhlmann A, Elsner K, Kotzerke J, Glatting G, Rentschler M et al. Sensitivity in detecting osseous lesions depends on anatomic localization: planar bone scintigraphy versus 18F PET J Nucl Med. 1999;40:1623-1629.</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>Cook GJ, Houston S, Rubens R, Maisey MN, Fogelman I. Detection of bone metastases in breast cancer by 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions. J Clin Oncol. 1998;16:3375-3379.</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>Patchell RA, Tibbs PA, Regine WF, Payne R, Saris S, Kryscio RJ et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: A randomised trial. The Lancet. 2005;366:643-648.</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>Witham TF, Khavkin YA, Gallia GL, Wolinsky JP, Gokaslan ZL. Surgery insight: current management of epidural spinal cord compression from metastatic spine disease. Nat Clin Pract Neurol. 2006;2:87-94.</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>Bartels RH, van der Linden YM, van der Graaf WT. Spinal extradural metastasis: review of current treatment options. CA Cancer J Clin. 2008;58:245-259.</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>Popovic M, Lemke M, Zeng L, Chen E, Nguyen J, Thavarajah N et al. Comparing prognostic factors in patients with spinal metastases: a literature review. Expert Rev Pharmacoecon Outcomes Res. 2012;12:345-356.</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation>Bauer HC, Wedin R. Survival after surgery for spinal and extremity metastases. Prognostication in 241 patients. Acta Orthop Scand. 1995;66:143-146.</mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation>Sioutos PJ, Arbit E, Meshulam CF, Galicich JH. Spinal metastases from solid tumors. Analysis of factors affecting survival. Cancer. 1995;76:1453-1459.</mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation>Tokuhashi Y, Matsuzaki H, Oda H, Oshima M, Ryu J. A revised scoring system for preoperative evaluation of metastatic spine tumor prognosis. Spine (Phila Pa 1976). 2005;30:2186-2191.</mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation>Tomita K, Kawahara N, Kobayashi T, Yoshida A, Murakami H, Akamaru T Surgical strategy for spinal metastases. Spine (Phila Pa 1976). 2001;26:298-306.</mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation>Tokuhashi Y Matsuzaki H, Toriyama S, Kawano H, Ohsaka S. Scoring system for the preoperative evaluation of metastatic spine tumor prognosis. Spine (Phila Pa 1976). 1990;15:1110-1113.</mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation>Wibmer C, Leithner A, Hofmann G, Clar H, Kapitan M, Berghold A et al. Survival analysis of254 patients after manifestation of spinal metastases: Evaluation of seven preoperative scoring systems. Spine (Phila Pa 1976). 2011;36:1977-1986.</mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation>Leithner A, Radl R, Gruber G, Hochegger M, Leithner K, Welkerling H et al. Predictive value of seven preoperative prognostic scoring systems for spinal metastases. Eur Spine J. 2008;17:1488-1495.</mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation>Chen H, Xiao J, Yang X, Zhang F, Yuan W Preoperative scoring systems and prognostic factors for patients with spinal metastases from hepatocellular carcinoma. Spine (Phila Pa 1976). 2010;35:E1339-1346.</mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation>Kaloostian PE, Yurter A, Zadnik PL, Sciubba DM, Gokaslan ZL. Current paradigms for metastatic spinal disease: an evidence-based review. Ann Surg Oncol. 2014;21:248-262.</mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation>Majeed H, Kumar S, Bommireddy R, Klezl Z, Calthorpe D. Accuracy of prognostic scores in decision making and predicting outcomes in metastatic spine disease. Ann R Coll Surg Engl. 2012;94:28-33.</mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation>Gregory TM, Coriat R, Mir O. Prognostic scoring systems for spinal metastases in the era of anti-VEGF therapies. Spine (Phila Pa 1976). 2013;38:965-966.</mixed-citation></ref><ref id="B52"><label>52.</label><mixed-citation>Beuselinck B, Oudard S, Rixe O, Wolter P, Blesius A, Ayllon J et al. Negative impact of bone metastasis on outcome in clear-cell renal cell carcinoma treated with sunitinib. Ann Oncol. 2011;22:794-800.</mixed-citation></ref><ref id="B53"><label>53.</label><mixed-citation>Fisher CG, DiPaola CP, Ryken TC, Bilsky MH, Shaffrey CI, Berven SH, et al. A novel classification system for spinal instability in neoplastic disease: An evidence-based approach and expert consensus from the spine oncology study group. Spine. 2010;35:E1221-E1229.</mixed-citation></ref><ref id="B54"><label>54.</label><mixed-citation>Fourney DR, Frangou EM, Ryken TC, Dipaola CP, Shaffrey CI, Berven SH, et al. Spinal instability neoplastic score: an analysis of reliability and validity from the spine oncology study group. J Clin Oncol. 2011;29:3072-3077.</mixed-citation></ref><ref id="B55"><label>55.</label><mixed-citation>Teixeira WG, Coutinho PR, Marchese LD, Narazaki DK, Cristante AF, Teixeira MJ et al. Interobserver agreement for the spine instability neoplastic score varies according to the experience of the evaluator. Clinics (Sao Paulo). 2013;68:213-218.</mixed-citation></ref><ref id="B56"><label>56.</label><mixed-citation>Campos M, Urrutia J, Zamora T, Roman J et al. The Spine Instability Neoplastic Score: an independent reliability and reproducibility analysis. Spine J. 2013.</mixed-citation></ref><ref id="B57"><label>57.</label><mixed-citation>Пиголкин ЮИ, Должанский ОВ, Глоба ИВ. Осложнения онкологических заболеваний и наступление внезапной смерти. Избранные вопросы судебно-медицинской экспертизы. Хабаровск. 2016;15:155-156.</mixed-citation></ref><ref id="B58"><label>58.</label><mixed-citation>Пиголкин ЮИ, Кильдюшов ЕМ, Шилова МА, Боева СЕ, Захаров СН, Глоба ИВ. Судебно-медицинская характеристика внезапной смерти при онкологической патологии. Вестник судебной медицины. Новосибирск. 2016;(2):8-11.</mixed-citation></ref><ref id="B59"><label>59.</label><mixed-citation>C. Rory Goodwin, Mohamed H. Khattab, Eric W Sankey, Benjamin D. Elder et al. Factors Associated with Life Expectancy in Patients with Metastatic Spine Disease from Adenocarcinoma of the Lung. Global Spine J. 2015;5:417-424. DOI: 10.1055/s-0035-1554778.</mixed-citation></ref><ref id="B60"><label>60.</label><mixed-citation>Santini D, Daniele S, Barni S et al. Natural history of non-small-cell lung cancer with bone metastases. Sci Rep. 2015;5:18670. DOI: 10.1038/SREP18670.</mixed-citation></ref><ref id="B61"><label>61.</label><mixed-citation>Matheus Fernandes de Oliveira, Jose Marcus Rotta, Ricardo Vieira Botelho Survival analysis in patients with metastatic spinal disease: the influence of surgery, histology, clinical and neurologic status. Arq Neuropsiquiatr. 2015;73(4):330-335. DOI: 10.1590/0004-282X20150003.</mixed-citation></ref><ref id="B62"><label>62.</label><mixed-citation>Chenglong Zhao, Zhichao Zhang, Nanzhe Zhong, Tianqi Fan et al. Outcomes and prognostic factors for surgically treated patients with breast cancer spine metastases. Journal of Bone Oncology. 2018;(12):38-43. DOI: 10.1016/j. jbo.2018.03.003.</mixed-citation></ref><ref id="B63"><label>63.</label><mixed-citation>Wibmer C, Leithner A, Hofmann G, Clar H, Kapitan M, Berghold A et al. Survival analysis of 254 patients after manifestation of spinal metastases: evaluation of seven preoperative scoring systems. Spine. 2011;36(23):1977-1986. DOI: 10.1097/Brs.0b013e3182011f84.</mixed-citation></ref><ref id="B64"><label>64.</label><mixed-citation>Le R, Tran J D, Lizaso M et al. Surgical Intervention vs. Radiation Therapy: The Shifting Paradigm in Treating Metastatic Spinal Disease. Cureus. 2018;10(10):e3406. DOI: 10.7759/ cureus.3406.</mixed-citation></ref><ref id="B65"><label>65.</label><mixed-citation>George R, Jeba J, Ramkumar G et al. Interventions for the treatment of metastatic extradural spinal cord compression in adults. Cochrane Database Syst Rev. 2015;9:CD006716. DOI: 10.1002/14651858.CD006716.pub3.</mixed-citation></ref><ref id="B66"><label>66.</label><mixed-citation>Payne WG, Walusimbi MS, Blue ML, Mosiello G, Wright TE, Robson MC. Radiated groin wounds: pitfalls in reconstruction. Am Surg. 2003;69:994-997.</mixed-citation></ref><ref id="B67"><label>67.</label><mixed-citation>Itshayek E, Yamada J, Bilsky M, Schmidt M, Shaffrey C, Gerszten P et al. Timing of surgery and radiotherapy in the management of metastatic spine disease: a systematic review. Int J Oncol. 2010;36:533-544. DOI: 10.3892/ijo_00000527.</mixed-citation></ref><ref id="B68"><label>68.</label><mixed-citation>Ghogawala Z, Mansfield FL, Borges LF. Spinal radiation before surgical decompression adversely affects outcomes of surgery for symptomatic metastatic spinal cord compression. Spine. 2001;26:818-8-24. DOI: 10.1097/00007632-200104010-00025.</mixed-citation></ref><ref id="B69"><label>69.</label><mixed-citation>Wang J, Boerma M, Fu Q, Hauer-Jensen M. Radiation responses in skin and connective tissues: effect on wound healing and surgical outcome. Hernia. 2006;10:502-506. DOI: 10.1007/s10029-006-0150-y.</mixed-citation></ref><ref id="B70"><label>70.</label><mixed-citation>Payne WG, Naidu DK, Wheeler CK, Barkoe D et al. Wound healing in patients with cancer. Eplasty. 2008:68-90.</mixed-citation></ref><ref id="B71"><label>71.</label><mixed-citation>Conti Alfredo, G liz Acker, Anne Kluge, Franziska Loebel et al. Decision Making in Patients With Metastatic Spine. The Role of Minimally Invasive Treatment Modalities. Front. Oncol. 19 September 2019. DOI: 10.3389/fonc.2019.00915.</mixed-citation></ref><ref id="B72"><label>72.</label><mixed-citation>Sciubba DM, Gokaslan ZL, Suk I, Suki D et al. Positive and negative prognostic variables for patients undergoing spine surgery for metastatic breast disease. Eur Spine J. 2007;16:1659-1667.</mixed-citation></ref><ref id="B73"><label>73.</label><mixed-citation>Simmons ED, Zheng Y. Vertebral tumors: surgical versus nonsurgical treatment. Clin Orthop Relat Res. 2006;443:233-247.</mixed-citation></ref><ref id="B74"><label>74.</label><mixed-citation>Yu HH, Hoffe SE. Beyond the conventional role of external-beam radiation therapy for skeletal metastases: new technologies and stereotactic directions. Cancer Control. 2012;19:129-136.</mixed-citation></ref><ref id="B75"><label>75.</label><mixed-citation>Townsend PW, Rosenthal HG, Smalley SR, Cozad SC. Impact of postoperative radiation therapy and other perioperative factors on outcome after orthopedic stabilization of impending or pathologic fractures due to metastatic disease. J Clin Oncol. 1994;12:2345-2350.</mixed-citation></ref><ref id="B76"><label>76.</label><mixed-citation>Sze WM, Shelley M, Held I, Mason M. Palliation of metastatic bone pain: Single fraction versus multifraction radiotherapy - a systematic review of the randomised trials. Cochrane Database Syst Rev. 2004;CD004721.</mixed-citation></ref><ref id="B77"><label>77.</label><mixed-citation>Chow E, Zeng L, Salvo N, Dennis K, Tsao M, Lutz S. Update on the systematic review of palliative radiotherapy trials for bone metastases. Clin Oncol (R Coll Radiol). 2012;24:112-124.</mixed-citation></ref><ref id="B78"><label>78.</label><mixed-citation>Gerszten PC, Mendel E, Yamada Y Radiotherapy and radiosurgery for metastatic spine disease: what are the options, indications, and outcomes? Spine (Phila Pa 1976). 2009;34:S78-92.</mixed-citation></ref><ref id="B79"><label>79.</label><mixed-citation>Maranzano E, Latini P. Effectiveness of radiation therapy without surgery in metastatic spinal cord compression: final results from a prospective trial. Int J Radiat Oncol Biol Phys. 1995;32:959-967.</mixed-citation></ref><ref id="B80"><label>80.</label><mixed-citation>Sheehan JP, Shaffrey CI, Schlesinger D, Williams BJ et al. Radiosurgery in the treatment of spinal metastases: tumor control, survival, and quality of life after helical tomotherapy. Neurosurgery. 2009;65:1052-1061.</mixed-citation></ref><ref id="B81"><label>81.</label><mixed-citation>Wang Z, Nelson JW, Yoo S, Wu QJ et al. Refinement of treatment setup and target localization accuracy using three-dimensional cone-beam computed tomography for stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys. 2009;73:571-577.</mixed-citation></ref><ref id="B82"><label>82.</label><mixed-citation>Ho AK, Fu D, Cotrutz C, Hancock SL, Chang SD, Gibbs IC et al. A study of the accuracy of cyberknife spinal radiosurgery using skeletal structure tracking. Neurosurgery. 2007;60:ONS147-156.</mixed-citation></ref><ref id="B83"><label>83.</label><mixed-citation>Gerszten PC, Mendel E, Yamada Y. Radiotherapy and radiosurgery for metastatic spine disease: what are the options, indications, and outcomes? Spine (Phila Pa 1976). 2009;34:S78-92.</mixed-citation></ref><ref id="B84"><label>84.</label><mixed-citation>Gerszten PC, Burton SA, Ozhasoglu C, Welch WC. Radiosurgery for spinal metastases: clinical experience in 500 cases from a single institution. Spine (Phila Pa 1976). 2007;32:193-199.</mixed-citation></ref><ref id="B85"><label>85.</label><mixed-citation>Flickinger JC, Kondziolka D, Lunsford LD. Radiobiological analysis of tissue responses following radiosurgery. Technol Cancer Res Treat. 2003;2:87-92.</mixed-citation></ref><ref id="B86"><label>86.</label><mixed-citation>Moulding HD, Elder JB, Lis E, Lovelock DM et al. Local disease control after decompressive surgery and adjuvant high-dose single-fraction radiosurgery for spine metastases. J Neurosurg Spine. 2010;13:87-93.</mixed-citation></ref><ref id="B87"><label>87.</label><mixed-citation>Yamada Y Bilsky MH, Lovelock DM, Venkatraman ES, Toner S, Johnson J et al. High-dose, single-fraction image-guided intensity-modulated radiotherapy for metastatic spinal lesions. Int J Radiat Oncol Biol Phys. 2008;71:484-490.</mixed-citation></ref><ref id="B88"><label>88.</label><mixed-citation>Gerszten PC, Lunsford LD, Rutigliano MJ, Kondziolka D et al. Single-stage stereotactic diagnosis and radiosurgery: feasibility and cost implications. J Image Guid Surg. 1995;1:141-150.</mixed-citation></ref><ref id="B89"><label>89.</label><mixed-citation>Haley ML, Gerszten PC, Heron DE, Chang YF, Atteberry DS, Burton SA. Efficacy and cost-effectiveness analysis of external beam and stereotactic body radiation therapy in the treatment of spine metastases: a matched-pair analysis. J Neurosurg Spine. 2011;14:537-542.</mixed-citation></ref><ref id="B90"><label>90.</label><mixed-citation>Laufer I, Rubin DG, Lis E, Cox BW Stubblefield MD, Yamada Y et al. The NOMS framework: approach to the treatment of spinal metastatic tumors. Oncologist. 2013;18:744-751.</mixed-citation></ref><ref id="B91"><label>91.</label><mixed-citation>Laufer I, Iorgulescu JB, Chapman T Lis E et al. Local disease control for spinal metastases following “separation surgery” and adjuvant hypofractionated or high-dose single-fraction stereotactic radiosurgery: outcome analysis in 186 patients. J Neurosurg Spine. 2013;18:207-214.</mixed-citation></ref><ref id="B92"><label>92.</label><mixed-citation>Wang JC, Boland P, Mitra N, Yamada Y et al. Single-stage posterolateral transpedicular approach for resection of epidural metastatic spine tumors involving the vertebral body with circumferential reconstruction: Results in 140 patients: Invited submission from the joint section meeting on disorders of the spine and peripheral nerves, march 2004. Journal of Neurosurgery: Spine. 2004;1:287-298.</mixed-citation></ref><ref id="B93"><label>93.</label><mixed-citation>Chen KY, Ma HI, Chiang YH. Percutaneous transpedicular vertebroplasty with polymethyl methacrylate for pathological fracture of the spine. J Clin Neurosci. 2009;16:1300-1304.</mixed-citation></ref><ref id="B94"><label>94.</label><mixed-citation>Pilitsis JG, Rengachary SS. The role of vertebroplasty in metastatic spinal disease. Neurosurg Focus. 2001;11:e9.</mixed-citation></ref><ref id="B95"><label>95.</label><mixed-citation>Denaro V, Longo UG, Maffulli N, Denaro L. Vertebroplasty and kyphoplasty. Clin Cases Miner Bone Metab. 2009;6:125-130.</mixed-citation></ref><ref id="B96"><label>96.</label><mixed-citation>Kassamali RH, Ganeshan A, Hoey ET, Crowe PM, Douis H, Henderson J. Pain management in spinal metastases: the role of percutaneous vertebral augmentation. Ann Oncol. 2011;22:782-786.</mixed-citation></ref><ref id="B97"><label>97.</label><mixed-citation>Hulme PA, Krebs J, Ferguson SJ, Berlemann U. Vertebroplasty and kyphoplasty: a systematic review of 69 clinical studies. Spine (Phila Pa 1976). 2006;31:1983-2001.</mixed-citation></ref><ref id="B98"><label>98.</label><mixed-citation>Anselmetti GC, Manca A, Kanika K, Murphy K, Eminefendic H, Masala S et al. Temperature measurement during polymerization of bone cement in percutaneous vertebroplasty: an in vivo study in humans. Cardiovasc Intervent Radiol. 2009;32:491-498.</mixed-citation></ref><ref id="B99"><label>99.</label><mixed-citation>Yimin Y, Zhiwei R, Wei M, Jha R. Current status of percutaneous vertebroplasty and percutaneous kyphoplasty - a review. Med Sci Monit. 2013;19:826-836.</mixed-citation></ref><ref id="B100"><label>100.</label><mixed-citation>Yu MK, Buys SS. Medical management of skeletal metastasis. Neurosurg Clin N Am. 2004;15:529-536.</mixed-citation></ref><ref id="B101"><label>101.</label><mixed-citation>Morandi P, Rouzier R, Altundag K, Buzdar AU. The role of aromatase inhibitors in the adjuvant treatment of breast carcinoma: The M. D. anderson cancer center evidence-based approach. Cancer. 2004;101:1482-1489.</mixed-citation></ref><ref id="B102"><label>102.</label><mixed-citation>Клинические рекомендации по применению остеомодифицирующих агентов у пациентов с метастазами в кости злокачественных опухолей. Ассоциация онкологов России. М., 2014.</mixed-citation></ref><ref id="B103"><label>103.</label><mixed-citation>Снеговой АВ, Багрова СГ, Болотина ЛВ, Владимирова ЛЮ, Горбунова ВА, Когония ЛМ и соавт. Профилактика и лечение патологии костной ткани остеомодифицирующими агентами (ОМА) при злокачественных новообразованиях. Злокачественные опухоли. 2016;(4/2):390-393.</mixed-citation></ref><ref id="B104"><label>104.</label><mixed-citation>Rosen LS, Gordon D, Tchekmedyian S, Yanagihara R et al. Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors: A phase III, double-blind, randomized trial the zoledronic acid lung cancer and other solid tumors study group. J Clin Oncol. 2003;21:3150-3157.</mixed-citation></ref><ref id="B105"><label>105.</label><mixed-citation>Saad F, Gleason DM, Murray R, Tchekmedyian S, Venner P, Lacombe L et al. A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma. J Natl Cancer Inst. 2002;94:1458-1468.</mixed-citation></ref><ref id="B106"><label>106.</label><mixed-citation>Morgan G, Lipton A. Antitumor effects and anticancer applications of bisphosphonates. Semin Oncol. 2010;37 Suppl 2:S30-40.</mixed-citation></ref><ref id="B107"><label>107.</label><mixed-citation>Fizazi K, Carducci M, Smith M, Damiao R et al. Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study. Lancet. 2011;377:813-822.</mixed-citation></ref><ref id="B108"><label>108.</label><mixed-citation>Bartels RH, van der Linden YM, van der Graaf WT. Spinal extradural metastasis: review of current treatment options. CA Cancer J Clin. 2008;58:245-259.</mixed-citation></ref><ref id="B109"><label>109.</label><mixed-citation>Posner J. Neurological complications of cancer. Philadephia: FA Davis. 1995.</mixed-citation></ref><ref id="B110"><label>110.</label><mixed-citation>Gerszten PC, Germanwala A, Burton SA, Welch WC, Ozhasoglu C, Vogel WJ. Combination kyphoplasty and spinal radiosurgery: A new treatment paradigm for pathological fractures. J Neurosurg Spine. 2005;3:296-301.</mixed-citation></ref><ref id="B111"><label>111.</label><mixed-citation>Gerszten PC, Monaco EA 3rd. Complete percutaneous treatment of vertebral body tumors causing spinal canal compromise using a transpedicular cavitation, cement augmentation, and radiosurgical technique. Neurosurg Focus. 2009;27:E9.</mixed-citation></ref><ref id="B112"><label>112.</label><mixed-citation>Georgy BA, Wong W. Plasma-mediated radiofrequency ablation assisted percutaneous cement injection for treating advanced malignant vertebral compression fractures. AJNR Am J Neuroradiol. 2007;28:700-705.</mixed-citation></ref><ref id="B113"><label>113.</label><mixed-citation>Dupuy DE, Liu D, Hartfeil D, Hanna L, Blume JD, Ahrar K et al. Percutaneous radiofrequency ablation of painful osseous metastases: a multicenter American College of Radiology Imaging Network trial. Cancer. 2010;116:989-997.</mixed-citation></ref><ref id="B114"><label>114.</label><mixed-citation>Kurup AN, Callstrom MR. Ablation of skeletal metastases: current status. J Vasc Interv Radiol. 2010;21:S242-250.</mixed-citation></ref><ref id="B115"><label>115.</label><mixed-citation>Kollender Y, Meller I, Bickels J, Flusser G et al. Role of adjuvant cryosurgery in intralesional treatment of sacral tumors. Cancer. 2003;97:2830-2838.</mixed-citation></ref></ref-list></back></article>
